Summary Yuhan Corporation (Yuhan) researches, develops, manufactures and markets pharmaceutical products. The company offers API's and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, beta-lactase inhibitors, PEGlyated compounds and anti-histamines. It offers finished goods for the treatment of coronary artery disease, hypertension, hyperlipidemia, cerebral thrombosis and other diseases. The company provides custom synthesis services for other pharmaceutical and biopharmaceutical companies. It offers APIs and finished products in domestic and also international market. Yuhan operates R&D and manufacturing facilities in Seoul. It offers its products and services across the world through its sales and distribution branches. Yuhan is headquartered in Seoul, South Korea. Yuhan Corporation (000100) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their... Research Beam Model: Research Beam Product ID: 1138522 250 USD New
Yuhan Corporation (000100) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Yuhan Corporation (000100) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : September   2016
  • Pages : 25
  • Publisher : GlobalData
 
 
 
Summary

Yuhan Corporation (Yuhan) researches, develops, manufactures and markets pharmaceutical products. The company offers API's and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, beta-lactase inhibitors, PEGlyated compounds and anti-histamines. It offers finished goods for the treatment of coronary artery disease, hypertension, hyperlipidemia, cerebral thrombosis and other diseases. The company provides custom synthesis services for other pharmaceutical and biopharmaceutical companies. It offers APIs and finished products in domestic and also international market. Yuhan operates R&D and manufacturing facilities in Seoul. It offers its products and services across the world through its sales and distribution branches. Yuhan is headquartered in Seoul, South Korea.

Yuhan Corporation (000100) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Yuhan Corporation, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Yuhan Corporation, Medical Devices Deals, 2010 to YTD 2016 10
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Yuhan Corporation, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Sorrento Therapeutics to Form Joint Venture with Yuhan 12
Licensing Agreements 13
Shandong Luoxin Pharma Enters into Licensing Agreement with Yuhan for YH25448 13
Cevec Pharma Enters Into Licensing Agreement With Yuhan To Develop Therapeutic Proteins 14
Ensoltek Enters Into Licensing Agreement With Yuhan For Peniel 1000 15
Yuhan Enters Into Licensing Agreement With Gilead Sciences For Viread 16
Equity Offering 17
Sorrento Therapeutics Raises USD10 Million in Private Placement of Shares and Warrants 17
Acquisition 19
Yuhan Completes Acquisition Of 9.1% Stake In Hanall For US$27 Million 19
Yuhan Completes Acquisition Of 20% Stake In Ensoltek For US$4 Million 21
Yuhan Corporation - Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25List of Tables
Yuhan Corporation, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Yuhan Corporation, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Yuhan Corporation, Deals By Therapy Area, 2010 to YTD 2016 8
Yuhan Corporation, Medical Devices Deals, 2010 to YTD 2016 10
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Sorrento Therapeutics to Form Joint Venture with Yuhan 12
Shandong Luoxin Pharma Enters into Licensing Agreement with Yuhan for YH25448 13
Cevec Pharma Enters Into Licensing Agreement With Yuhan To Develop Therapeutic Proteins 14
Ensoltek Enters Into Licensing Agreement With Yuhan For Peniel 1000 15
Yuhan Enters Into Licensing Agreement With Gilead Sciences For Viread 16
Sorrento Therapeutics Raises USD10 Million in Private Placement of Shares and Warrants 17
Yuhan Completes Acquisition Of 9.1% Stake In Hanall For US$27 Million 19
Yuhan Completes Acquisition Of 20% Stake In Ensoltek For US$4 Million 21
Yuhan Corporation, Key Competitors 22
Yuhan Corporation, Key Employees 23
Yuhan Corporation, Other Locations 24
Yuhan Corporation, Subsidiaries 24List of Figures
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Yuhan Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Yuhan Corporation, Medical Devices Deals, 2010 to YTD 2016 10
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter